COVID-19 Funding Opportunities

IPaT is sharing internal, federal, nonprofit, and industry funding opportunities related to the COVID-19 outbreak. Check back frequently for new programs and additional opportunities. Visit the Research at Georgia Tech website.

Federal Funding Opportunities  



Title:  Rapid Acceleration of Diagnostics (RADx)

Agency:  National Institute of Biomedical Imaging and Bioengineering
Amount:  up to $500M
Deadline:  
Rolling submission and selection process
Description:  The National Institute of Biomedical Imaging and Bioengineering (NIBIB) urgently solicits proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx) is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches.

Funding Opportunity Number:  NSF 20-052
Title:  Rapid Response Research Grants on the Coronavirus Disease 2019 (COVID-19)
Agency: National Science Foundation
Amount:  $200,000+
Deadline:  None

Description:  Funding is to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.
•    See NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19).
•    RAPID Program Guidelines are specified in the NSF Grant Proposal Guide.

Funding Opportunity Number:  PAR-20-256
Title:  Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
Agency:  Department of Health and Human Services – NIH11
Amount: 
Deadline:  July 7, 2021
Description:  The purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAIDs vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial.

Nonprofit Funding Opportunities 

 
Title:  Spark Grants

Agency:  Michelson 20MM Foundation​
Amount:
Deadline:  Rolling submission and selection process
Description:  With the COVID-19 crisis severely impacting the educational space, the Michelson 20MM Foundation is launching a new round of the Spark Grant program to fill urgent needs for education organizations that are well-aligned with the following target outcomes: increasing access to and efficiency of emergency student aid programs; decreasing the “digital divide” through ensuring students, faculty, and nonprofits have access to devices, high-speed internet, technology solutions, and IT support; and accelerating the growth and shift to online and remote education via support for students and faculty.